| NAME |
MORPHINE SO4 50MG/NALTREXONE HCL 2MG CAP,SA |
| VA GENERIC NAME |
MORPHINE/NALTREXONE |
| DOSAGE FORM |
CAP,SA |
| FDA MED GUIDE |
Morphine-Naltrexone_(Embeda)_(2019).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule II |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| NATIONAL FORMULARY NAME |
MORPHINE/NALTREXONE CAP,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
MORPHINE 50MG/NALTREXONE 2MG SA CAP |
| VA PRODUCT IDENTIFIER |
M0892 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4029088 |
| EFFECTIVE DATE/TIME |
-
- 2009-10-01 00:00:00
- STATUS: ACTIVE
|
